ORGANIGRAM Corporate Presentation
Investment Thesis
✓ One of the lowest costs of cultivation¹ among Canadian licensed producers
✓ Sales in all 10 provinces
✓ Strong execution, cost management culture reflected in operating and financial results
✓ Positioned well for Rec 2.0 -edibles and derivative products launch:
■ 2.0 portfolio initially focused on 2 most popular form factors, vape pens and edibles
■ As planned, began shipping vape cartridges in December 2019
✓ Invested in biosynthesis to produce cannabinoids at a fraction of traditional cultivation costs
✓ Sufficient capital resources to fund operating and capital expenditure plans
✓ Attractive market valuation relative to Canadian LP peers
✓ Disciplined capital allocation focused on maximizing return on investment for shareholders
1
19
Cost of cultivation per gram is a non-IFRS measure with no standardized meaning under IFRS. See the Company's Q1 2020 MD&A for definition and
reconciliation to IFRS.
ORGANIGRAMView entire presentation